NCT00385307View on ClinicalTrials.gov

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)

PHASE3CompletedINTERVENTIONAL

Enrollment

680

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Major Depressive Disorder

Interventions

DRUG

amibegron (SR58611A)

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY